MYRIAD GENETICS INC — Director's Dealing 2014

Oct 2, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2014-09-30

Reporting Person: Evans James S (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-30	Common Stock	M	4978.0	$9.04	Acquired	53106	Direct
2014-09-30	Common Stock	S	4978.0	$38.9879	Disposed	48128	Direct
2014-09-30	Common Stock	M	16872.0	$8.63	Acquired	65000	Direct
2014-09-30	Common Stock	S	16872.0	$38.9879	Disposed	48128	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-09-30	Non-Qualified Stock Option (right to buy)	$8.63	M	16872.0	Disposed	2016-02-16	Common Stock (16872)	Direct
2014-09-30	Non-Qualified Stock Option (right to buy)	$9.04	M	4978.0	Disposed	2016-09-06	Common Stock (4978)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.